
Sweeteners May Have Hidden Metabolic Costs, New Analysis Finds
A review of 21 randomized trials links artificial and low-calorie sweeteners to higher fasting insulin and HbA1c, with a possible reduction in insulin sensitivity; gut microbiome changes may be involved, and higher consumption could relate to greater cardiometabolic risk, though causality isn’t proven. While avoiding large amounts of added sugar is prudent, replacing sugar with these sweeteners may be better than sugar, but not risk-free.













